Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002801 · ClinicalTrials.gov registry record · Phase 1
Combination Chemotherapy and Radiation Therapy in Treating Patients With Colorectal Cancer
A Phase 1 study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
NCT00002801: Completed Phase 1 study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00002801 is a Phase 1 study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002801, a Phase 1 study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug and combining radiation therapy with chemotherapy may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of combination chemotherapy consisting of fluorouracil-uracil and leucovorin plus radiation therapy in treating patients with colorectal cancer who have undergone surgery to remove the tumor.
Interventions
- DRUG leucovorin calcium
- RADIATION radiation therapy
- DRUG tegafur-uracil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 1996-04 |
| Est. Completion | 2009-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002801
The ClinicalTrials.gov registry entry for NCT00002801 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which leucovorin calcium is the first listed.
NCT00002801 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00002801 about?
NCT00002801 is a clinical study titled "Combination Chemotherapy and Radiation Therapy in Treating Patients With Colorectal Cancer". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug and combining radiation therapy with chemotherapy may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of combination chemothe...
What is the current status of trial NCT00002801?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 1996-04. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00002801?
The interventions under investigation include: leucovorin calcium (DRUG), radiation therapy (RADIATION), tegafur-uracil (DRUG).
Who is sponsoring clinical trial NCT00002801?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.